| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Hair Loss > Understanding Gradual Hair Loss |
|
E-Articles - Understanding Gradual Hair Loss
Most people routinely lose between 70 and 150 hairs from their scalp each day, mainly through washing, brushing, and combi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ng. But there is tremendous variation in the number of hairs that people shed each day, depending on the number of scalp h ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in irs and the length of the growth cycle. As people age, their rate of new hair growth slows down, resulting in a gradual th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. inning. Scalp hair starts to thin when more hairs are lost through normal shedding than the scalp is able to renew. About here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe 40% of the density of scalp hair has to be lost before thinning of the hair becomes noticeable. Hair loss can be caused b d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro : Heredity issues. Most balding is caused by a genetic predisposition - in other words, it's part of a person's gen ucts have become life saving products for the pharmaceutical companies who doesnt have many innovative molecules in their product pipeline and have been inc etic makeup. This is called male pattern baldness, or hereditary balding or thinning. It is the most common cause of thinn easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ng hair. Illness, certain physical conditions, or their treatments. This can include high fever, thyroid disease, nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hildbirth, inadequate protein in the diet, iron deficiency, cancer treatments, the use of certain medications, and other c and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ auses. Hair may be lost in two ways: In patchy hair loss, well-defined areas of hair are lost while the remaining ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi calp retains a good covering of hair. In generalized hair loss, there is a uniform thinning over the entire scalp ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ith no areas of normal hair growth. The medical term for hair loss is alopecia. There are different classifications of al dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod opecia: Alopecia areata is a disease in which well-defined bald patches occur. It usually clears completely within cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin to 12 months without treatment. Alopecia totalis is an uncommon condition in which all hair on the scalp is lost. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen The cause is unknown, and the baldness is usually permanent. Alopecia universalis is a total loss of hair on all p t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel arts of the body. Androgenetic alopecia is balding caused by heredity. It can affect both men and women, although ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust omen with this inherited tendency do not become totally bald. The condition can start in a person's teens, twenties, or th y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products rties. If you notice you are shedding hair excessively after combing or brushing, or if your hair is becoming thinner, yo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de u should consult with your primary care provider or a dermatologist (a physician who specializes in treating skin and hair elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip problems). A doctor can determine if disease is present and whether or not the hair loss will respond to medical treatment tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Succeed as a Virtual Assistant Part 2 Is Your VoIP Hosted PBX Provider Blind to Your Troubles? Improving Your Body Immune System
|